Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 2
2021 2
2022 3
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab.
Almuiña-Varela P, García-Quintanilla L, Rodríguez-Cid MJ, Gil-Martínez M, Abraldes MJ, Gómez-Ulla F, Estany-Gestal A, Alcántara-Espinosa JM, Fernández-Rodríguez M, Fernández-Ferreiro A. Almuiña-Varela P, et al. Among authors: garcia quintanilla l. Pharmaceuticals (Basel). 2024 Jan 25;17(2):157. doi: 10.3390/ph17020157. Pharmaceuticals (Basel). 2024. PMID: 38399372 Free PMC article.
The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration.
García-Quintanilla L, Almuiña-Varela P, Rodríguez-Cid MJ, Gil-Martínez M, Abraldes MJ, Gómez-Ulla F, González-Barcia M, Mondelo-García C, Estany-Gestal A, Otero-Espinar FJ, Fernández-Rodríguez M, Fernández-Ferreiro A. García-Quintanilla L, et al. Pharmaceutics. 2024 Jan 13;16(1):105. doi: 10.3390/pharmaceutics16010105. Pharmaceutics. 2024. PMID: 38258115 Free PMC article.
[Translated article] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.
Parra AP, Ramos N, Perurena-Prieto J, Manrique-Rodríguez S, Climente M, Quintanilla LG, Escolano Á, Miarons M; grupo PK-ECU-ORPHAR. Parra AP, et al. Among authors: quintanilla lg. Farm Hosp. 2024 Jan-Feb;48(1):T16-T22. doi: 10.1016/j.farma.2023.09.009. Epub 2023 Dec 5. Farm Hosp. 2024. PMID: 38057242 Free article. English, Spanish.
Enhancing Therapeutic Drug Monitoring in Inflammatory Bowel Disease: A Comparative Analysis of Rapid Point-of-Care Infliximab, Adalimumab and Anti-Drug Antibodies' Determination against ELISA.
Toja-Camba FJ, García-Quintanilla L, Rodríguez-Martinez L, Tomine J, Cajade-Pascual F, Feitosa C, Zarra-Ferro I, Barreiro-De-Acosta M, González-López J, Mondelo-García C, Fernández-Ferreiro A. Toja-Camba FJ, et al. Among authors: garcia quintanilla l. Pharmaceutics. 2023 Nov 11;15(11):2615. doi: 10.3390/pharmaceutics15112615. Pharmaceutics. 2023. PMID: 38004593 Free PMC article.
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration.
García-Quintanilla L, Almuiña-Varela P, Maroñas O, Gil-Rodriguez A, Rodríguez-Cid MJ, Gil-Martinez M, Abraldes MJ, Gómez-Ulla de Irazazabal F, González-Barcia M, Mondelo-Garcia C, Cruz R, Estany-Gestal A, Fernández-Rodríguez M, Fernández-Ferreiro A. García-Quintanilla L, et al. Invest Ophthalmol Vis Sci. 2023 Oct 3;64(13):34. doi: 10.1167/iovs.64.13.34. Invest Ophthalmol Vis Sci. 2023. PMID: 37862026 Free PMC article.
Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy.
Pau Parra A, Ramos N, Perurena-Prieto J, Manrique-Rodríguez S, Climente M, García Quintanilla L, Escolano Á, Miarons M; en nombre del grupo PK-ECU-ORPHAR. Pau Parra A, et al. Among authors: garcia quintanilla l. Farm Hosp. 2024 Jan-Feb;48(1):16-22. doi: 10.1016/j.farma.2023.07.009. Epub 2023 Aug 22. Farm Hosp. 2024. PMID: 37612186 Free article. English, Spanish.
Correction: A Review of Population Pharmacokinetic Analyses of Linezolid.
Bandín-Vilar E, García-Quintanilla L, Castro-Balado A, Zarra-Ferro I, González-Barcia M, Campos-Toimil M, Mangas-Sanjuan V, Mondelo-García C, Fernández-Ferreiro A. Bandín-Vilar E, et al. Among authors: garcia quintanilla l. Clin Pharmacokinet. 2023 Sep;62(9):1331. doi: 10.1007/s40262-023-01295-7. Clin Pharmacokinet. 2023. PMID: 37535241 No abstract available.
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence.
Castro-Balado A, Bandín-Vilar E, Cuartero-Martínez A, García-Quintanilla L, Hermelo-Vidal G, García-Otero X, Rodríguez-Martínez L, Mateos J, Hernández-Blanco M, Aguiar P, Zarra-Ferro I, González-Barcia M, Mondelo-García C, Otero-Espinar FJ, Fernández-Ferreiro A. Castro-Balado A, et al. Among authors: garcia quintanilla l. Pharmaceutics. 2022 Oct 15;14(10):2194. doi: 10.3390/pharmaceutics14102194. Pharmaceutics. 2022. PMID: 36297629 Free PMC article.
A Review of Population Pharmacokinetic Analyses of Linezolid.
Bandín-Vilar E, García-Quintanilla L, Castro-Balado A, Zarra-Ferro I, González-Barcia M, Campos-Toimil M, Mangas-Sanjuan V, Mondelo-García C, Fernández-Ferreiro A. Bandín-Vilar E, et al. Among authors: garcia quintanilla l. Clin Pharmacokinet. 2022 Jun;61(6):789-817. doi: 10.1007/s40262-022-01125-2. Epub 2022 Jun 14. Clin Pharmacokinet. 2022. PMID: 35699914 Free PMC article. Review.
16 results